Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.15
Delayed Data
As of 4:00pm ET
 +0.02 / +0.94%
Today’s Change
1.81
Today|||52-Week Range
3.35
+3.86%
Year-to-Date

Today’s Trading

Previous close2.13
Today’s open2.11
Day’s range2.06 - 2.15
Volume997,069
Average volume (3 months)1,358,702
Market cap$339.0M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,054.47%
P/E ratioNM
Price/Sales21.65
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
CRISCuris Inc-0.04-1.66%
AGENAgenus Inc+0.02+0.39%
VYGRVoyager Therapeutics...-0.17-1.36%
BLCMBellicum Pharmaceuti...-0.08-0.66%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$36.4M
Annual profit (last year)$46.0K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs